Title: Adult Immunization 2006
1- Adult Immunization 2006
- Satellite Broadcast
- December 7, 2006
- Human Papillomavirus Vaccine Segment
Graphics subject to change This material in the
public domain
2Human Papillomavirus
- More than 100 types
- More than 60 cutaneous types
- Can lead to skin warts
- 40 mucosal types
- High risk types (particularly 16 and 18)
- cervical cell abnormalities
- certain anogenital cancers
- Low risk types (particularly 6 and 11)
- cervical cell abnormalities- usually resolve
spontaneously and do not lead to cancer - genital warts
- respiratory papillomatosis
3Natural History of HPV Infection
Up to Decades
Within 1 Year
1-5 Years
InitialHPV Infection
Persistent Infection
CIN 2/3
Cervical Cancer
CIN 1
Cleared HPV Infection
4Cancer Attributable to HPV - 2002
Attributable Fraction 100 90 40 40 12
Estimated Cases 12,000 3,700 4,480 1,000 10,000
Cancer Cervical Anal Vulvar/vaginal Penile Oral/ph
arynx
5HPV-associated Conditions
Estimated 70 30-50 10
- HPV 16, 18
- Cervical cancer
- High/low grade cervical
- abnormalities
- Anal, Vulvar, Vaginal, Penile
- Head and neck cancers
- HPV 6, 11
- Low grade cervical
- abnormalities
- Genital warts
- RRP
10 90 90
6Human PapillomavirusVaccine Recommendations
- Women 19-26 years of age are recommended to
receive the HPV series if they have not already
received it
provisional (as of December 2007)
7Human PapillomavirusVaccine
- 3 dose series
- Administered intramuscularly
- Schedule 0, 2 months, and 6 months
- Minimum intervals
- dose 1-2 4 weeks
- dose 2-3 12 weeks
8Human PapillomavirusVaccine
- Effective only in preventing infection, not in
curing disease, or treating a current infection - Recommended for all women in the approved age
range (through 26 years) regardless of sexual
history, prior HPV infection, or prior disease
9Human Papillomavirus VaccineContraindications
and Precautions
- Severe allergic reaction to a vaccine component
or following a prior dose - Moderate or severe acute illness
- Defer HPV vaccine until after pregnancy